Morgan Stanley Maintains Overweight on ArcBest, Lowers Price Target to $125
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley analyst Ravi Shanker has maintained an Overweight rating on ArcBest (NASDAQ:ARCB) but lowered the price target from $136 to $125.

July 06, 2023 | 12:28 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Morgan Stanley has maintained an Overweight rating on ArcBest but lowered the price target from $136 to $125.
The news is directly about ArcBest. While the Overweight rating is maintained, the lowering of the price target might indicate a slightly less optimistic outlook for the company's stock in the short term. However, the impact on the stock price is uncertain as the rating is still positive.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100